Patient-Reported Self-Efficacy, Anxiety, and Health-Related Quality of Life During Chemotherapy: Results From a Longitudinal Study

Papadopoulou, Constantina; Kotronoulas, Grigorios; Schneider, Annegret; Miller, Morven; McBride, Jackie; Polly, Zoe; Bettles, Simon; Whitehouse, Alison S.; McCann, Lisa; Kearney, Nora; Maguire, Roma

doi:10.1188/17.onf.127-136

Cited by 38 publications

(36 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There is an array of evidence to suggest that online interventions can have a positive impact on self-efficacy and patient activation levels [30,32,33,107]. Growing evidence suggests that self-efficacy and patient activation play a significant role in symptom management and quality of life throughout cancer treatment [108,109] and are associated with an array of improved health behaviors and health outcomes [110-112] and lower use of hospital resources [113]. The reviewed systems generally demonstrate positive outcomes for patients as has been found in other reviews [31].…”

Section: Discussionmentioning

confidence: 99%

Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review

Warrington¹,

Absolom²,

Conner³

et al. 2019

J Med Internet Res

142

121

View full text Add to dashboard Cite

Background There has been a dramatic increase in the development of electronic systems to support cancer patients to report and manage side effects of treatment from home. Systems vary in the features they offer to patients, which may affect how patients engage with them and how they improve patient-centered outcomes. Objective This review aimed to (1) describe the features and functions of existing electronic symptom reporting systems (eg, symptom monitoring, tailored self-management advice), and (2) explore which features may be associated with patient engagement and patient-centered outcomes. Methods The review was registered with the International Prospective Register of Systematic Reviews (PROSPERO) and followed guidelines from the Centre for Reviews and Dissemination (University of York, United Kingdom). Primary searches were undertaken of MEDLINE, Embase, PsycInfo, Web of Science, Cochrane Central Register of Controlled Trials, and the Health Technology Assessment databases. Secondary searches were undertaken by screening reference lists and citations. Two researchers applied broad inclusion criteria to identify and select relevant records. Data were extracted and summarized using Microsoft Excel. In order to meet the aims, the study selection, data extraction, and data synthesis comprised two stages: (1) identifying and characterizing available systems and (2) summarizing data on patient engagement and patient-centered outcomes. Results We identified 77 publications relating to 41 distinct systems. In Stage 1, all publications were included (N=77). The features identified that supported clinicians and care were facility for health professionals to remotely access and monitor patient-reported data (24/41, 58%) and function to send alerts to health professionals for severe symptoms (17/41, 41%). Features that supported patients were facility for patients to monitor/review their symptom reports over time (eg, graphs) (19/41, 46%), general patient information about cancer treatment and side effects (17/41, 41%), tailored automated patient advice on symptom management (12/41, 29%), feature for patients to communicate with the health care team (6/41, 15%), and a forum for patients to communicate with one another (4/41, 10%). In Stage 2, only publications that included some data on patient engagement or patient-centered outcomes were included (N=29). A lack of consistency between studies in how engagement was defined, measured, or reported, and a wide range of methods chosen to evaluate systems meant that it was not possible to compare across studies or make conclusions on relationships with system features. Conclusions Electronic systems have the potential to help patients manage side effects of cancer treatment, with some evidence to suggest a positive effect on patient-centered outcomes. However, comparison across studies is difficult due to the wide range of assessment tools us...

show abstract

Section: Discussionmentioning

confidence: 99%

Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review

Warrington¹,

Absolom²,

Conner³

et al. 2019

J Med Internet Res

142

121

View full text Add to dashboard Cite

show abstract

“…Studies from western societies have identified several factors affecting HRQoL in women with BC. Those factors include socio-demographic characteristics, such as age [9], marital status, economic problems [10], and the experience of daily difficulties in work [11], as well as clinical and psychological characteristics of BC survivors, such as stage of disease [12], pain, stress [13], depression and anxiety [14], social relationships [15], variations in self-confidence, self-efficacy [16], and the development of harmful sentiments. In addition, HRQoL was found to be affected by the therapeutic procedures used [17].A recent review and meta-analysis evaluating the QoL of patients with BC in the Middle East revealed that fewer than one-third of patients (21%) had good QoL [18].…”

mentioning

confidence: 99%

Factors Associated with Health-Related Quality of Life in Women with Breast Cancer in the Middle East: A Systematic Review

Haidari

Abou-Abbas

Nerich

et al. 2020

Cancers

View full text Add to dashboard Cite

Objectives: The aim of the present systematic review was to identify the factors that potentially influence health-related quality of life (HRQoL) in women with breast cancer (BC) in the Middle East. Methods: A systematic search of the PubMed, Ovid Medline, Cochrane, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Scopus, and Ebscohost databases was conducted to identify all relevant articles published in peer-reviewed journals up to April 2018. The keywords were "Health related quality of life", "Breast Cancer", and "Middle East countries". The Newcastle-Ottawa (NOS) scale was used to evaluate the methodological quality of the included studies. Due to the methodological heterogeneity of the identified studies, no statistical pooling of the individual effect estimates was carried out; instead, the results were summarized descriptively. Results: A total of 5668 articles were screened and 33 studies were retained. The vast majority of these studies were cross-sectional and only two were longitudinal prospective studies. Concerning the methodological quality, only 39% were of high quality. Our comprehensive literature review identified several modifiable and non-modifiable risk factors associated with HRQoL, including sociodemographic, clinical, and treatment-related factors as well as behavioral and psychosocial factors. Conclusion: This study has many implications for clinical practice and may provide a framework for establishing policy interventions to improve HRQoL among women with BC. Healthcare systems in the Middle East are encouraged to develop interventional programs targeting modifiable factors, particularly socio-demographic, behavioral, and psychosocial factors.The Middle East is a region located in western Asia and extends into North Africa, with an estimated population of over 411 million. It comprises 15 countries with different ethnic groups holding different cultures, norms, and beliefs. Although BC incidence rates are lower in the Middle East compared to other western societies, they have substantially increased over the last few decades [1]. According to GLOBOCAN estimates, approximately 119,985 (34.2%) new BC cases and 48,661 (24.9%) cancer-related deaths occurred in 2018 [1]. Furthermore, a large proportion of women are diagnosed with BC at younger age, i.e., under 40 years old, and at an advanced stage, where BC is generally aggressive and requires mastectomy [2]. In most countries of the Middle East, BC is still considered a sensitive and taboo topic, surrounded by shame and silence. Most Middle Eastern societies mention it as "that other disease" and many women are petrified to talk about it [3]. The perception of BC as incurable and its fatality are also a concern. Therefore, a diagnosis of BC can be a devastating event and can expose Middle Eastern women to a high burden of psychological suffering that could adversely affect their health-related quality of life (HRQoL).According to Osoba et al., HRQoL is "a multidimensional construct that includes perceptions of b...

show abstract

“…We therefore chose a period of 16 weeks assuming that most patients are still under treatment. We also assume that the SN©P might affect patient’s estimation on symptom interference over this period, because patient’s positive attitude for self-management has been shown to be associated with increased physical, emotional and functional well-being over 6 months 53. Other outcomes will include mean changes in symptom intensity, perceived self-efficacy and quality of nursing care assessed four times over a period of 16 weeks.…”

Section: Methods and Analysismentioning

confidence: 99%

Implementation of the Symptom Navi © Programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi© Pilot Study)

Bana

Ribi

Kropf-Staub³

et al. 2019

BMJ Open

View full text Add to dashboard Cite

IntroductionSelf-management interventions show promising results on symptom outcomes and self-management behaviours. The Symptom Navi© Programme (SN©P) is a nurse-led intervention supporting patients’ symptom self-management during anticancer treatment. It consists of written patient information (Symptom Navi© Flyers (SN©Flyers)), semistructured consultations and a training manual for nurses.Methods and analysisThis pilot study will evaluate the implementation of the SN©P based on the Reach Effectiveness—Adoption Implementation Maintenance framework at Swiss outpatient cancer centres. We will use a cluster-randomised design and randomise the nine participating centres to the intervention or usual care group. We expect to include 140 adult cancer patients receiving first-line systemic anticancer treatment. Trained nurses at the intervention clusters will provide at least two semistructured consultations with the involvement of SN©Flyers. Outcomes include patients’ accrual and retention rates, patient-reported interference of symptoms with daily functions, symptom burden, perceived self-efficacy, quality of nursing care, nurse-reported facilitators and barriers of adopting the programme, nurses’ fidelity of providing the intervention as intended, and patients’ safety (patients timely reporting of severe symptoms). We will use validated questionnaires for patient-reported outcomes, focus group interviews with nurses and individual interviews with oncologists. Linear mixed models will be used to analyse patient-reported outcomes. Focus group and individual interviews will be analysed by thematic analysis.Ethics and disseminationThe Symptom Navi© Pilot Study has been reviewed and approved by Swiss Ethic Committee Bern (KEK-BE: 2017–00020). Results of the study will be disseminated in peer-reviewed journal and at scientific conferences.Trial registration numberNCT03649984; Pre-results.

show abstract

Patient-Reported Self-Efficacy, Anxiety, and Health-Related Quality of Life During Chemotherapy: Results From a Longitudinal Study

Abstract: The current study suggests self-efficacy enhancement should be a key component of psycho-behavioral programs designed to support patients with cancer throughout chemotherapy.

Cited by 38 publications

References 51 publications

Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review

Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review

Factors Associated with Health-Related Quality of Life in Women with Breast Cancer in the Middle East: A Systematic Review

Implementation of the Symptom Navi © Programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi© Pilot Study)

Contact Info

Product

Resources

About